SALL4 and hepatocellular carcinoma: These results altogether suggest that HBV or HCV may increase the risk of HCC development in a SALL4-dependent manner, and that SALL4 diagnostic/prognostic biomarker may perform the best in patients whose HCC is caused by hepatitis infections.